FDA Investigator Sara H Gabel
Sara H Gabel has inspections in 1 countries as of 22 Sep 2023. Sara H Gabel has collaborated with a combined 1113 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Anita Narula, PhD,
Astrida B Mattson,
Christopher R Czajka,
Crystal A Harlan,
Crystal Monroy,
David J Gomes,
Dawn E Barkans,
Devon M Shoop,
Diane L Raccasi,
Dogbeda F Mackenzie,
Douglas A Campbell,
Elizabeth S Howell,
Ephrem Hunde, PhD,
Estefania Fernandez,
James D Hildreth,
Jeffrey M Watson,
Jeffrey P Raimondi,
Joanne M Fukuda,
John Burr,
John R Myung,
Julia N Alvarez,
Kathryn A Krentz,
Kelley,
Kelvin X Sanders,
Khoa Nathanv Tran,
Kristin M Abaonza,
Lakecha N Lewis,
Lance M De Souza, MBA,
Lawrence Y Lee, PhD,
Ligia M Sanders,
Lisa K Capron,
Marcus F Yambot,
Maria Cruz Fisher,
Maria I Cruz Fisher,
Michael S Araneta,
Michelle Y Clark Stuart,
Monica Commerford, PhD,
Nancy A Saxenian Emmons,
Nicholas L Hunt,
Paul F Rader,
Paul Rader,
Peter E Baker,
Rachel C Stanton,
Rebecca Rodriguez,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Roger F Zabinski,
Rowena S Nguyen,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Savini,
Sonia R Peterson,
Sonya L Karsik,
State Agency,
Steven M Galvez,
Taichun Qin, PhD,
Terri L Dodds,
Thomas J Arista,
Thomas W Gordon,
Tracy Denison, PhD,
Tracy K Li,
William V Millar
Sara H Gabel's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2022 | FDA 483 | Advanced Cosmetic Research Laboratories, Inc. - Form 483, 2022-04-27 |
March, 2023 | FDA 483 | Airgas Usa, LLC - Form 483, 2023-03-09 |
July, 2022 | FDA 483 | OFD Biopharma, LLC - Form 483, 2022-07-01 |
July, 2023 | EIR | Glaukos Corporation - EIR, 2023-08-01 |
September, 2023 | FDA 483 | Precision Equine, LLC - Form 483, 2023-09-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more